DNA-mediated immunization to hepatitis B virus envelope proteins: PreS antigen secretion enhances the humoral response

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 617-623

  Prange, Reinhild ^a   Werr, Margaret ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

DNA immunization; HBV; PreS1 domain

Indexed keywords

DNA; DNA VACCINE; ENVELOPE PROTEIN; HEPATITIS B VACCINE; PLASMID DNA; VIRUS ANTIGEN;

ADOLESCENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; HEPATITIS B; HUMORAL IMMUNITY; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECRETION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; COS CELLS; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; MICE; MICE, INBRED BALB C; PROTEIN PRECURSORS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 0033605350     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00243-6     Document Type: Article

References (26)

1. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y., Sato A., Boyer J., Williams W.V., Weiner D.B. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 90:1993;4156.
2. Xiang Z.Q., Spitalnik S.L., Cheng J., Erikson J., Wojczyk B., Ertl H.C.J. Immune responses to nucleic acid vaccines to rabies virus. Virology. 209:1995;569.
3. Ulmer J.B., Donnelly J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745.
4. Michel M.-L., Davis H.L., Schleef M., Mancini M., Tiollais P., Whalen R.G. DNA-mediated immunization of the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA. 92:1995;5307.
5. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 61:1988;1942.
6. Valenzuela P., Medina A., Rutter W.J., Ammerer G., Hall B.D. Synthesis and assembly of hepatitis B surface antigen particles in yeast. Nature. 298:1982;347.
7. Michel M.-L., Pontisso P., Sobczak E., Malpièce Y., Streeck R.E., Tiollais P. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc. Natl. Acad. Sci. USA. 81:1984;7708.
8. Rutgers T., Hauser P., DeWilde M. Potential future recombinant vaccines. In: Ellis R.E., editor. Hepatitis B vaccines in clinical practice. New York, Basel, Hong Kong: Dekker, 1993:383.
9. Hassett D.E., Whitton J.L. DNA immunization. Trends Microbiol. 4:1996;307.
10. Davis H.L., Mancini M., Michel M.-L., Whalen R.G. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine. 14:1996;910.
11. Mancini M., Hadchouel M., Davis H.L., Whalen R.G., Tiollais P., Michel M.-L. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc. Natl. Acad. Sci. USA. 93:1996;12496.
12. Heermann K.H., Goldmann U., Schwartz W., Seyffarth T., Baumgarten H., Gerlich W.H. Large surface proteins of hepatitis B virus containing the pre-s sequence. J. Virol. 52:1984;396.
13. Neurath A.R., Seto B., Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine. 7:1989;234.
14. Neurath A.R., Kent S.B.H., Strick N., Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell. 46:1986;429.
15. Kuroki K., Russnak R., Ganem D. Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum. Mol. Cell. Biol. 9:1989;4459.
16. Prange R., Clemen A., Streeck R.E. Myristylation is involved in intracellular retention of the hepatitis B virus envelope proteins. J. Virol. 65:1991;3919.
17. Cox G.J., Zamb T.J., Babiuk L.A. Bovine herpes virus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:1993;1164.
18. Donnelly J.J., Martinez D., Jansen K.U., Ellis R.W., Montgomery D.L., Liu M.A. Protection against papillomavirus with a polynucleotide vaccine. J. Infect. Dis. 173:1996;314.
19. Geissler M., Gesien A., Tokushige K., Wands J.R. Enhancement of cellular and humoral responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158:1997;1231.
20. Prange R., Werr M., Birkner M., Hilfrich R., Streeck R.E. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes. J. Gen. Virol. 76:1995;2131.
21. Werr M., Prange R. Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles. J. Virol. 72:1998;144.
22. Ganem D. Hepadnaviridae and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Virology. 3rd edn. Philadelphia: Lippincott-Raven, 1996:2703.
23. Milich D.R. T- and B-cell recognition of hepatitis B viral antigens. Immunol. Today. 9:1988;380.
24. Geissler M., Tokushige K., Chante C.C., Zurawski V.R., Wands J.R. Cellular and humoral response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology. 112:1997;1307.
25. Davis H.L., Brazalot Millan C.L., Watkins S.C. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen expressing plasmid DNA. Gene Ther. 4:1997;181.
26. Major M.E., Vitvitski L., Mink M.A., Schleef M., Whalen R.G., Trepo C., Inchauspé G. DNA-based immunization with chimeric vectors for the induction of immune responses against hepatitis C virus nucleocapsid. J. Virol. 69:1995;5798.